[1] |
Johnson RT. Prion diseases[J]. Lancet Neurology,2005,4(10):635-642.
|
[2] |
Ladogana A,Puopolo M,Croes EA, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada[J]. Neurology,2005,64(9):1586-1591.
|
[3] |
Zerr I,Kallenberg K,Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease[J]. Brain,2009,132(10):2659-2668.
|
[4] |
中国痴呆与认知障碍诊治指南写作组,中国医师协会神经内科医师分会认知障碍疾病专业委员会. 2018中国痴呆与认知障碍诊治指南(八):快速进展性痴呆的诊断[J]. 中华医学杂志,2018,98(21):1650-1652.
|
[5] |
Haywood AM. Mechanisms of disease: Transmissible spongiform encephalopathies[J]. J Neurol Neurosurg Psychiatry,1997,63(3):388-390.
|
[6] |
Rabinovici GD,Wang PN,Levin J, et al. First symptom in sporadic Creutzfeldt-Jakob disease[J]. Neurology,2006,66(2):286-287.
|
[7] |
Wang LH,Bucelli RC,Erica P, et al. Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease[J]. J Neurol,2013,260(2):498-506.
|
[8] |
Rosseau G. Normal pressure hydrocephalus[J]. Dis Mon 2011,57(10):615-624.
|
[9] |
Macfarlane RG,Wroe SJ,Collinge J, et al. Neuroimaging findings in human prion disease[J]. J Neurol Neurosurg Psychiatry,2007,78(7):664-670.
|
[10] |
Eisenmenger L,Porter MC,Carswell CJ, et al. Evolution of diffusion-weighted magnetic resonance imaging signal abnormality in sporadic Creutzfeldt-Jakob disease, with histopathological correlation[J]. JAMA Neurol,2016,73(1):76-84.
|
[11] |
Zeidler M,Sellar RJ,Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease[J]. Lancet, 2000,355(9213):1412-1418.
|
[12] |
Manners DN,Parchi P,Tonon C, et al. Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease[J]. Neurology, 2009,72(16):1425-1431.
|
[13] |
Vitali P,Maccagnano E,Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias[J]. Neurology,2011,76(20):1711-1719.
|
[14] |
Sanchezjuan P,Green A,Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease[J]. Neurology,2006,67(4):637-643.
|
[15] |
Hamlin C,Puoti G,Berri S, et al. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease[J]. Neurology,2012,79(6):547- 552.
|
[16] |
Fukushima R,Shiga Y,Nakamura M, et al. MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrPSc type 2 in Japan[J]. J Neurol Neurosurg Psychiatry,2004,75(3):485-487.
|
[17] |
Zanusso G,Monaco S,Pocchiari M, et al. Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease[J]. Nat Rev Neurol,2016,12(6):325-333.
|
[18] |
Paul B. A new standard for the laboratory diagnosis of sporadic Creutzfeldt-Jakob disease[J]. JAMA Neurology,2017,74(2):144-145.
|
[19] |
Ena J. Prions: Who should worry about them?[J]. Arch Med Res,2005,36(6):622-627.
|
[20] |
Paterson RW,Torreschae CC,Kuo AL, et al. Differential diagnosis of Jakob-Creutzfeldt disease[J]. Arch Neurol,2012,69(12):1578-1582.
|
[21] |
Aguzzi A,Lakkaraju AKK,Frontzek K. Toward therapy of human prion diseases[J]. Annu Rev Pharmacol Toxicol,2018,58:331-351.
|